Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 16, 2019 Filed Apr 18, 2019 20:12 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 600 | $182.24 | $109,344.00 |
DisclosureSEC source: 0001209191-19-025236 · doc4.xml · nonDerivative · entry 10 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,503 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F10 · price: Open market sales reported on this line occurred at a weighted average price of $182.24 (range $182.06 to $182.53). Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:12 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 600 | $181.49 | $108,894.00 |
DisclosureSEC source: 0001209191-19-025236 · doc4.xml · nonDerivative · entry 9 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,103 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F9 · price: Open market sales reported on this line occurred at a weighted average price of $181.49 (range $180.97 to $181.95). Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:12 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 425 | $179.84 | $76,432.00 |
DisclosureSEC source: 0001209191-19-025236 · doc4.xml · nonDerivative · entry 8 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,703 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $179.84 (range $179.63 to $180.30). Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:12 UTC |
Parini MichaelEVP, CL&AO
|
Exercise / conversionCommon Stock | 2,125 | $90.29 | $191,866.25 |
DisclosureSEC source: 0001209191-19-025236 · doc4.xml · nonDerivative · entry 7 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:12 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 660 | $184.44 | $121,730.40 |
DisclosureSEC source: 0001209191-19-025236 · doc4.xml · nonDerivative · entry 6 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,003 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $184.44 (range $184.18 to $184.71). Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:12 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 300 | $183.26 | $54,978.00 |
DisclosureSEC source: 0001209191-19-025236 · doc4.xml · nonDerivative · entry 5 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,663 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $183.26 (range $183.13 to $183.48). Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:12 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 1,605 | $182.19 | $292,414.95 |
DisclosureSEC source: 0001209191-19-025236 · doc4.xml · nonDerivative · entry 4 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,963 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $182.19 (range $181.84 to $182.67). Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:12 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 815 | $181.31 | $147,767.65 |
DisclosureSEC source: 0001209191-19-025236 · doc4.xml · nonDerivative · entry 3 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,568 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $181.31 (range $180.82 to $181.67). Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:12 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 870 | $179.91 | $156,521.70 |
DisclosureSEC source: 0001209191-19-025236 · doc4.xml · nonDerivative · entry 2 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,383 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $179.91 (range $179.68 to $180.55). F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:12 UTC |
Parini MichaelEVP, CL&AO
|
Exercise / conversionCommon Stock | 4,250 | $122.45 | $520,412.50 |
DisclosureSEC source: 0001209191-19-025236 · doc4.xml · nonDerivative · entry 1 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 20:30 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 320 | $183.61 | $58,755.20 |
DisclosureSEC source: 0001209191-19-024991 · doc4.xml · nonDerivative · entry 3 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,240 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 20:30 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 2,712 | $182.29 | $494,370.48 |
DisclosureSEC source: 0001209191-19-024991 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,560 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $182.29 (range $181.86 to $182.54). Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 20:30 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 2,592 | $180.95 | $469,022.40 |
DisclosureSEC source: 0001209191-19-024991 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,272 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $180.95 (range $180.47 to $181.33). F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 20:42 UTC |
SACHS BRUCE IDirector
|
GrantDeferred Stock Units · Derivative | 246.873 | $182.28 | $45,000.01 |
DisclosureSEC source: 0001209191-19-025000 · doc4.xml · derivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,577.063 Underlying: Common Stock · 246.873 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. Read SEC document |
| April 10, 2019 Filed Apr 12, 2019 20:00 UTC |
WAGNER CHARLES F JREVP and CFO
|
GrantStock Option (Right to Buy) · Derivative | 9,532 | $0.00 Strike: $189.38 | $0.00 |
DisclosureSEC source: 0001209191-19-024466 · doc4.xml · derivative · entry 2 WAGNER CHARLES F JR · CIK 0001223348 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,532 Underlying: Common Stock · 9,532 shares Expires 2029-04-09 F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 4/10/2019. Read SEC document |
| April 10, 2019 Filed Apr 12, 2019 20:00 UTC |
WAGNER CHARLES F JREVP and CFO
|
GrantCommon Stock | 3,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-024466 · doc4.xml · nonDerivative · entry 1 WAGNER CHARLES F JR · CIK 0001223348 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,697 F1 · shares: Restricted stock unit award that vests in three annual installments on 4/30/20, 4/30/21, and 4/30/22. Read SEC document |
| February 21, 2019 Filed Feb 22, 2019 21:12 UTC |
CARNEY LLOYDDirector
|
GrantCommon Stock | 2,161 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-012524 · doc4.xml · nonDerivative · entry 1 CARNEY LLOYD · CIK 0001204424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,161 F1 · shares: Restricted stock grant vests on 2/29/2020. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:21 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 400 | $188.59 | $75,436.00 |
DisclosureSEC source: 0001209191-19-011991 · doc4.xml · nonDerivative · entry 3 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,553 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $188.59 (range $188.36 to $188.86). Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:21 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 651 | $187.40 | $121,997.40 |
DisclosureSEC source: 0001209191-19-011991 · doc4.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,953 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $187.40 (range $187.12 to $187.96). Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:21 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 4,573 | $186.81 | $854,282.13 |
DisclosureSEC source: 0001209191-19-011991 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,604 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $186.81 (range $186.09 to $187.08). F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:22 UTC |
Kewalramani ReshmaEVP and CMO
|
SaleCommon Stock | 100 | $188.49 | $18,849.00 |
DisclosureSEC source: 0001209191-19-011994 · doc4.xml · nonDerivative · entry 3 Kewalramani Reshma · CIK 0001735944 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,736 F1 · kind: Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $188.49 (range $188.36 to $188.70). Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:22 UTC |
Kewalramani ReshmaEVP and CMO
|
SaleCommon Stock | 202 | $187.27 | $37,828.54 |
DisclosureSEC source: 0001209191-19-011994 · doc4.xml · nonDerivative · entry 2 Kewalramani Reshma · CIK 0001735944 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,836 F1 · kind: Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $187.27 (range $187.11 to $187.49). Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:22 UTC |
Kewalramani ReshmaEVP and CMO
|
SaleCommon Stock | 1,186 | $186.75 | $221,485.50 |
DisclosureSEC source: 0001209191-19-011994 · doc4.xml · nonDerivative · entry 1 Kewalramani Reshma · CIK 0001735944 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,038 F1 · kind: Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $186.75 (range $186.10 to $187.05). F3 · price: Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:24 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 1,200 | $188.61 | $226,332.00 |
DisclosureSEC source: 0001209191-19-011999 · doc4.xml · nonDerivative · entry 3 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,195 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $188.61 (range $188.50 to $188.73). Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:24 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 2,700 | $187.43 | $506,061.00 |
DisclosureSEC source: 0001209191-19-011999 · doc4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,395 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $187.43 (range $187.17 to $188.09). Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:24 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 17,097 | $186.80 | $3,193,719.60 |
DisclosureSEC source: 0001209191-19-011999 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,095 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $187.14 (range $186.16 to $187.14). F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:26 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 400 | $188.54 | $75,416.00 |
DisclosureSEC source: 0001209191-19-012005 · doc4.xml · nonDerivative · entry 3 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,003 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $188.54 (range $188.36 to $188.85). Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:26 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 600 | $187.42 | $112,452.00 |
DisclosureSEC source: 0001209191-19-012005 · doc4.xml · nonDerivative · entry 2 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,403 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $187.42 (range $187.12 to $187.96). Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:26 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 4,624 | $186.79 | $863,716.96 |
DisclosureSEC source: 0001209191-19-012005 · doc4.xml · nonDerivative · entry 1 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,003 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $186.79 (range $186.09 to $187.05). F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:27 UTC |
Silva Paul MSVP & Interim CFO
|
SaleCommon Stock | 160 | $188.70 | $30,192.00 |
DisclosureSEC source: 0001209191-19-012010 · doc4.xml · nonDerivative · entry 3 Silva Paul M · CIK 0001446372 · SVP & Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,759 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:27 UTC |
Silva Paul MSVP & Interim CFO
|
SaleCommon Stock | 984 | $187.10 | $184,106.40 |
DisclosureSEC source: 0001209191-19-012010 · doc4.xml · nonDerivative · entry 2 Silva Paul M · CIK 0001446372 · SVP & Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,919 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $187.10 (range $186.95 to $187.42). Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:27 UTC |
Silva Paul MSVP & Interim CFO
|
SaleCommon Stock | 1,668 | $186.72 | $311,448.96 |
DisclosureSEC source: 0001209191-19-012010 · doc4.xml · nonDerivative · entry 1 Silva Paul M · CIK 0001446372 · SVP & Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,903 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $186.72 (range $185.93 to $186.93). F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:27 UTC |
Silva Paul MSVP & Interim CFO
|
SaleCommon Stock | 715 | $181.09 | $129,479.35 |
DisclosureSEC source: 0001209191-19-009630 · doc4.xml · nonDerivative · entry 3 Silva Paul M · CIK 0001446372 · SVP & Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,571 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $181.09 (range $180.88 to $181.36). Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:27 UTC |
Silva Paul MSVP & Interim CFO
|
SaleCommon Stock | 2,100 | $180.38 | $378,798.00 |
DisclosureSEC source: 0001209191-19-009630 · doc4.xml · nonDerivative · entry 2 Silva Paul M · CIK 0001446372 · SVP & Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,286 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $179.35 (range $178.75 to $179.64). F4 · price: Open market sales reported on this line occurred at a weighted average price of $180.38 (range $179.78 to $180.76). Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:27 UTC |
Silva Paul MSVP & Interim CFO
|
SaleCommon Stock | 1,400 | $179.35 | $251,090.00 |
DisclosureSEC source: 0001209191-19-009630 · doc4.xml · nonDerivative · entry 1 Silva Paul M · CIK 0001446372 · SVP & Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,386 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $179.35 (range $178.75 to $179.64). F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:33 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 2,762 | $181.00 | $499,922.00 |
DisclosureSEC source: 0001209191-19-009642 · doc4.xml · nonDerivative · entry 3 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,627 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $181.00 (range $180.76 to $181.37). Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:33 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 5,480 | $180.36 | $988,372.80 |
DisclosureSEC source: 0001209191-19-009642 · doc4.xml · nonDerivative · entry 2 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,389 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $180.36 (range $179.82 to $180.74). Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:33 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 3,894 | $179.48 | $698,895.12 |
DisclosureSEC source: 0001209191-19-009642 · doc4.xml · nonDerivative · entry 1 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,869 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $179.48 (range $178.75 to $179.74). F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:36 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 100 | $181.82 | $18,182.00 |
DisclosureSEC source: 0001209191-19-009652 · doc4.xml · nonDerivative · entry 4 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,177 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:36 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 6,937 | $181.03 | $1,255,805.11 |
DisclosureSEC source: 0001209191-19-009652 · doc4.xml · nonDerivative · entry 3 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,277 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $181.03 (range $180.76 to $181.52). Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:36 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 15,836 | $180.33 | $2,855,705.88 |
DisclosureSEC source: 0001209191-19-009652 · doc4.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,214 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $180.33 (range $179.77 to $180.74). Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:36 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 10,083 | $179.46 | $1,809,495.18 |
DisclosureSEC source: 0001209191-19-009652 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,050 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $179.46 (range $178.75 to $179.74). F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:37 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 7,501 | $181.03 | $1,357,906.03 |
DisclosureSEC source: 0001209191-19-009655 · doc4.xml · nonDerivative · entry 3 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,864 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $181.03 (range $180.77 to $181.59). Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:37 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 14,915 | $180.34 | $2,689,771.10 |
DisclosureSEC source: 0001209191-19-009655 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,365 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $180.34 (range $179.76 to $180.76). Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:37 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 10,657 | $179.44 | $1,912,292.08 |
DisclosureSEC source: 0001209191-19-009655 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,280 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $179.44 (range $178.75 to $179.74). F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:39 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 412 | $181.80 | $74,901.60 |
DisclosureSEC source: 0001209191-19-009663 · doc4.xml · nonDerivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,192 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $179.28 (range $178.47 to $179.47). F6 · price: Open market sales reported on this line occurred at a weighted average price of $181.80 (range $181.52 to $181.81). Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:39 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 48,651 | $180.81 | $8,796,587.31 |
DisclosureSEC source: 0001209191-19-009663 · doc4.xml · nonDerivative · entry 3 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,604 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $180.81 (range $180.48 to $181.45). Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:39 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 47,661 | $179.93 | $8,575,643.73 |
DisclosureSEC source: 0001209191-19-009663 · doc4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,255 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $179.93 (range $179.48 to $180.47). Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:39 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 14,707 | $179.28 | $2,636,670.96 |
DisclosureSEC source: 0001209191-19-009663 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,916 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $179.28 (range $178.47 to $179.47). F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:40 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 100 | $182.05 | $18,205.00 |
DisclosureSEC source: 0001209191-19-009667 · doc4.xml · nonDerivative · entry 4 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,165 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.